Drug Interactions between Hecoria and mycophenolate mofetil
This report displays the potential drug interactions for the following 2 drugs:
- Hecoria (tacrolimus)
- mycophenolate mofetil
Interactions between your drugs
No interactions were found between Hecoria and mycophenolate mofetil. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Hecoria is in the drug class calcineurin inhibitors.
- Hecoria is used to treat the following conditions:
- Mycophenolate mofetil is in the drug class selective immunosuppressants.
Mycophenolate mofetil is used to treat the following conditions:
- Autoimmune Hepatitis
- Bullous Pemphigoid
- Cogan's Syndrome
- Crohn's Disease
- Evan's Syndrome
- Graft-versus-host disease
- High Cholesterol
- Inflammatory Bowel Disease
- Linear IgA Disease
- Multiple Sclerosis
- Myasthenia Gravis
- Nephrotic Syndrome
- Organ Transplant, Rejection Prophylaxis
- Psoriatic Arthritis
- Pulmonary Fibrosis
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Ulcerative Colitis
Drug and food interactions
Applies to: Hecoria (tacrolimus)
Tacrolimus should be taken on a consistent schedule before or after you eat at the same times each day. Grapefruit and grapefruit juice may increase the amount of tacrolimus in your body. This can lead to potentially dangerous side effects and should be avoided. If you are already consuming grapefruit products, do not increase or decrease the amount of these products in your diet without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.